Navigation Links
Synvista Therapeutics Highlights Newly Published Data Demonstrating the Value of Haptoglobin Genotype Testing In People with Diabetes
Date:3/5/2008

Study Shows Statin and Antioxidant Therapy to be Superior to Statins Alone in Decreasing Cardiovascular Events in Diabetics with Haptoglobin 2-2

Genotype

MONTVALE, N.J., March 5 /PRNewswire-FirstCall/ -- Synvista Therapeutics, Inc. (Amex: SYI) announces the publication of a pre-planned sub-analysis from the ICARE study demonstrating that the addition of vitamin E to statin therapy prevented more cardiovascular events (heart attack, stroke and cardiovascular death) than statin therapy alone in patients with Diabetes Mellitus (DM) who tested positive for a genetic marker called Haptoglobin 2-2 (Hp2-2). This sub-analysis was published in the March issue of Arteriosclerosis, Thrombosis and Vascular Biology, a journal of the American Heart Association.

"These data are significant because they demonstrate that Haptoglobin testing may help physicians tailor optimal therapy for patients with diabetes who may be at risk for cardiovascular events. Physicians can better describe to their patients whether they are at high risk for a heart attack and whether they may anticipate a lower risk for heart attack if they take vitamin E. The knowledge of who would benefit from this nutriceutical is valuable for patients and physicians and may be cost saving for payers," said Noah Berkowitz, M.D., Ph.D., President and Chief Executive Officer of Synvista Therapeutics, Inc., which is developing a diagnostic product to identify Haptoglobin types. "This study demonstrates that positive clinical outcomes may be achieved with the application of patient selection. Thus, the 6,000,000 patients in the United States with diabetes and Hp2-2, who are at elevated risk for heart attack, could see that risk reduced by adding
'/>"/>

SOURCE Synvista Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Synvista Therapeutics to Present at the 10th Annual BIO CEO & Investor Conference
2. Synvista Therapeutics to Develop Topical Formulation of ALT-2074 for the Treatment of Psoriasis
3. Synvista Therapeutics to be Featured on Wallst.net
4. Synvista Therapeutics to Present at the BIO InvestorForum 2007
5. Cell Therapeutics, Inc. to Hold Conference Call to Update on Recent Transactions and Upcoming Milestones
6. M. Scott Harris, M.D., Joins Ocera Therapeutics, Inc., as Chief Medical Officer
7. CV Therapeutics Reports 2007 Fourth Quarter and Full Year Financial Results
8. TorreyPines Therapeutics to Present at Susquehanna Financial Groups Second Annual SIGnificant Options in Healthcare Conference
9. Hsiao Dee Lieu, M.D., F.A.C.C. Named VP of Clinical Research of Nile Therapeutics
10. The Diabetes Series 2008: Experts Speak About Developing Diabetes Therapeutics
11. CV Therapeutics Announces Presentations at the American College of Cardiology 57th Annual Scientific Session
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... British Columbia , March 2, ... OTCQB: IMLFF), a clinical stage biopharmaceutical company specializing ... announced that Craig Schneider , Chief Executive ... live webcast at VirtualInvestorConferences.com. DATE: Thursday, ... > click the red "register/ watch event ...
(Date:3/2/2015)... , March 2, 2015 VG Life ... therapies for autoimmune and infectious diseases, announced that ... issued an important new composition of matter patent ... the targeting of CLIP. U.S. ... underlying VG Life Sciences, VG1177, a synthetic peptide ...
(Date:2/28/2015)... AZ (PRWEB) February 28, 2015 Increasing its ... World Films launches its first three episodes of The GMO ... Mile Project this month, as it continues its mission to ... launch, the project's first phase, to “uncover the truth about ... of media. , The GMO Truth Podcast is an expansion ...
(Date:2/27/2015)... DUBLIN , Feb. 27, 2015 Research and Markets ... the "Global Market Report of Trypsin" report to ... Trypsin (CAS 9002-07-7) aims at providing comprehensive data on Trypsin ... Asia , North America , ... trends, pays close attention to Trypsin This report ...
Breaking Biology Technology:InMed Pharmaceuticals to Present Investor Webcast March 5 2VG Life Sciences Granted Key Composition Of Matter Patent 2VG Life Sciences Granted Key Composition Of Matter Patent 3The Walk a Mile Project Launches “GMO Truth” Podcast 2Global Market Report of Trypsin 2014-2018 2
... Largest Technology Matchmaking Event in the US Comes to Houston, ... 3-7, 2009 at the George R. Brown Convention Center, ... (NSTI), and the Clean Technology and Sustainable Industries,Organization (CTSI), today ... place May 3-7, 2009 at the George R. Brown,Convention Center ...
... New Boston Area Facility, NEW YORK, Oct. 27 ... is pioneering the pre-disease collection,processing and long-term storage of ... it has closed on a private placement financing,in the ... in launching,its adult stem cell collection network in the ...
... one Silver Bernays Mark of Merit award, for superior ... Industry Organization,s (BIO) 2008 BIO International Convention. The ... awards for the media kit it developed for Ichor ... in support of the Transportation Corridor Agencies, Toll Road ...
Cached Biology Technology:TechConnect World 2009 Matches Tomorrow's Technology Solutions with Today's Business Needs for Clean-Technology, Biotechnology and Nanotechnology 2TechConnect World 2009 Matches Tomorrow's Technology Solutions with Today's Business Needs for Clean-Technology, Biotechnology and Nanotechnology 3NeoStem Secures $250,000 in an Above Market Financing and Expands Its Relationship With New England Cryogenic Center, Inc. 2NeoStem Secures $250,000 in an Above Market Financing and Expands Its Relationship With New England Cryogenic Center, Inc. 3Gable PR Honored by PRSA San Diego Chapter with Three Awards for Client Programs 2Gable PR Honored by PRSA San Diego Chapter with Three Awards for Client Programs 3
(Date:2/12/2015)... OXFORD, Conn. , Feb. 12, 2015 ... ("NXT-ID" or the "Company"), a biometric authentication company focused ... it has filed provisional patent 62/113114 for ... MULTIPLE DEVICES. The patent further establishes NXT-ID,s ... to its intellectual property portfolio the ability for multiple ...
(Date:2/9/2015)...  Lintec of America recently announced an exclusive license ... macrostructures, including sheets, yarns and ribbons, developed at the ... the vast industrial resources of the global Lintec Group, ... of America is forming the Nano-Science and Technology Center ... on scaling up the manufacturing and commercialization of nano ...
(Date:2/5/2015)... SAN DIEGO , Jan. 26, 2015   Epic ... treatment of cancer, today announced that Murali Prahalad , ... Personalized Medicine World Conference (PMWC) 2015: Silicon Valley, ... Mountain View, Calif. on January 26-28, ... entitled, "CTCs Come of Age as Biomarkers." Last year, Epic ...
Breaking Biology News(10 mins):NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 2NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 4Epic Sciences to Present at Personalized Medicine World Conference 2015 on the Use of Circulating Tumor Cells as Cancer Biomarkers 2
... of the 2012 American College of Medical Genetics (ACMG) Foundation ... and Chairman Emeritus at the Miller School of Medicine at ... American College of Medical Genetics Foundation, was honored for his ... genetic research and for his role and leadership in the ...
... TV advert have on a viewer? How does it bring ... questions have existed alongside advertising ever since it began. Through ... Comunicacin, the Tecnalia Centre for Applied Research, and the UPV/EHU, ... a person to a series of television adverts. The ...
... This release is available in German . ... When pathogenic bacteria penetrate the body, they are the first ... molecules, thereby containing the risk. To this end, they release ... activate signal molecules. Scientists at the Max Planck Institute of ...
Cached Biology News:Renowned geneticist R. Rodney Howell receives ACMG Foundation Lifetime Achievement Award 2Renowned geneticist R. Rodney Howell receives ACMG Foundation Lifetime Achievement Award 3Renowned geneticist R. Rodney Howell receives ACMG Foundation Lifetime Achievement Award 4A study confirms that long commercials evoke stronger emotions 2New immune defense enzyme discovered 2New immune defense enzyme discovered 3
... in two product models - the 5000AT+ and ... that the 6000AT+ includes a membrane desolvation unit ... improved detection limits and reduced oxides. The Ultrasonic ... elements by 10-40 times. Note that with ICP-MS ...
...
... using a protein engineering approach that introduced amino ... wild-type DNase I. These changes markedly increase the ... is a versatile enzyme that has a 6-fold ... maintain at least 50% of peak activity in ...
... iTaq DNA polymerase is an ... for both conventional and real-time ... supplied at a concentration of ... includes 250 units polymerase, 1.25 ...
Biology Products: